Clenbuterol
Sponsors
Francis D. Pagani, Dwight Koeberl, M.D., Ph.D., University of Copenhagen, Duke University, Morten Hostrup, PhD
Conditions
Amyotrophic Lateral SclerosisDilated CardiomyopathyHeart FailureMuscle Hypertrophy in Healthy Young MenMuscular Dystrophy, FacioscapulohumeralPompe DiseasePompe Disease (Late-onset)Skeletal Muscle Physiology
Phase 1
Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure
TerminatedNCT00585546
Start: 2007-07-31End: 2010-03-31Updated: 2017-12-15
Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy
CompletedNCT01942590
Start: 2013-09-30End: 2016-09-02Updated: 2019-07-02
Clenbuterol to Target DUX4 in FSHD
RecruitingNCT06721299
Start: 2025-06-25End: 2028-07-01Target: 30Updated: 2026-02-25
Phase 2
Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease
WithdrawnNCT04094948
Start: 2023-01-01End: 2025-12-30Updated: 2022-08-17
Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis
CompletedNCT04245709
Start: 2020-02-10End: 2021-03-10Updated: 2022-09-06
A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy
RecruitingNCT06169046
Start: 2024-04-13End: 2027-12-31Target: 90Updated: 2024-04-15